This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, The Broad Institute, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,269 
1 out of 3,081 
1 out of 490 
Years Active: 2024
Title: Srivatsan Raghavan: Innovator in Cancer Treatment
Introduction
Srivatsan Raghavan is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer treatment. His work focuses on developing innovative compounds that target proliferative diseases, particularly pancreatic cancer.
Latest Patents
Raghavan holds a patent for "Cyclopentaimidazolones for the treatment of cancer." This patent describes compounds that are useful in treating various proliferative diseases. These compounds, along with their pharmaceutically acceptable salts, can be formulated into pharmaceutical compositions and utilized in methods for treating and preventing proliferative diseases, including cancer.
Career Highlights
Throughout his career, Raghavan has worked with prestigious organizations such as the Broad Institute, Inc. and Dana-Farber Cancer Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of his notable coworkers include Bruce Kuan-Yee Hua and Shubhroz Gill, who have also contributed to advancements in cancer treatment.
Conclusion
Srivatsan Raghavan's innovative work in developing treatments for cancer exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to pave the way for new therapeutic options for patients facing challenging diagnoses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile